Fred's Inc (FRED)

17.68
NASDAQ : Services
Prev Close 17.68
Day Low/High 0.00 / 0.00
52 Wk Low/High 7.88 / 21.77
Avg Volume 1.82M
Exchange NASDAQ
Shares Outstanding 37.91M
Market Cap 670.25M
EPS -0.20
P/E Ratio N/A
Div & Yield 0.24 (1.40%)

Latest News

Einhorn Takes Fred's Stake Amid Deal Review

Einhorn Takes Fred's Stake Amid Deal Review

The activist investor could be agitating behind-the-scenes to have Fred's sold after it picks up hundreds of stores required by the FTC to consumate a Walgreen-Rite Aid deal

Fred's Pharmacy Declares Quarterly Cash Dividend Of $0.06 Per Share

Fred's Pharmacy Declares Quarterly Cash Dividend Of $0.06 Per Share

Fred's, Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today announced that its Board of Directors has declared a quarterly cash dividend of $0.

What Buffett, Icahn and Other Billionaire Investors Are Buying in the Trump Era

What Buffett, Icahn and Other Billionaire Investors Are Buying in the Trump Era

Billionaire investors appear to see good times ahead with a fellow billionaire in the White House.

David Einhorn's Hedge Fund Just Bought Syngenta, Monsanto and Alcoa

David Einhorn's Hedge Fund Just Bought Syngenta, Monsanto and Alcoa

David Einhorn's hedge fund, Greenlight Capital, disclosed fresh positions in four stocks.

Billionaire David Einhorn Just Bought These 4 Stocks

Billionaire David Einhorn Just Bought These 4 Stocks

With nearly $800 million invested in the stock, Apple remains David Einhorn's top investment, but a he's buying up notable positions in some other companies, too.

Billionaire David Einhorn Just Bought These 4 Stocks

Billionaire David Einhorn Just Bought These 4 Stocks

Einhorn picked up new positions in Syngenta and others.

FRED Crosses Above Average Analyst Target

FRED Crosses Above Average Analyst Target

In recent trading, shares of Fred's Inc. have crossed above the average analyst 12-month target price of $15.50, changing hands for $16.01/share.

Fred's Pharmacy Announces Senior Management Appointments

Fred's Pharmacy Announces Senior Management Appointments

Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today announced three additions to its senior management team.

Fred's Pharmacy Reports January Sales

Fred's Pharmacy Reports January Sales

Fred's Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today reported sales for the four-week fiscal month of January 2017, fourth quarter 2016 and fiscal year 2016 ended January 28, 2017.

Fred's Pharmacy Comments On Extension To Merger Agreement

Fred's Pharmacy Comments On Extension To Merger Agreement

Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today issued the following statement regarding the agreement between Walgreens Boots Alliance, Inc.

Rite Aid Plummets After Walgreens Slashes Offer Price by Nearly $2 Billion

Rite Aid Plummets After Walgreens Slashes Offer Price by Nearly $2 Billion

Will this deal ever satisfy the FTC? Plus what Jim Cramer thinks.

Interesting FRED Put And Call Options For March 17th

Interesting FRED Put And Call Options For March 17th

Investors in Fred's Inc. saw new options become available this week, for the March 17th expiration.

Analysts' Actions -- Apple, Aetna, DineEquity, Silgan and More

Analysts' Actions -- Apple, Aetna, DineEquity, Silgan and More

Here are Tuesday's top research calls, including an upgrade for Silgan and downgrades for Apple, Aetna and DineEquity.

Why It's Unhealthy to Own Rite Aid, Plus Jim Cramer's Take

Why It's Unhealthy to Own Rite Aid, Plus Jim Cramer's Take

Will the merger with Walgreens go through? Investors -- even Jim Cramer -- can't be sure, and that is affecting the drug store stock.

Trading Battered Qualcomm and Rite Aid? Here's What to Do Now

Trading Battered Qualcomm and Rite Aid? Here's What to Do Now

Here's how to trade seven of the most active stocks on the market Monday.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AGI, FRED, IXYS, XRX Downgrades: ATRO, ENFC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Rite Aid Takes a Beating After Report of Walgreens Deal Fears

Rite Aid Takes a Beating After Report of Walgreens Deal Fears

Rite Aid shares fell in dramatic fashion on Friday.

Rite Aid Shares Tank on Reports FTC May Not Approve Deal With Walgreens

Rite Aid Shares Tank on Reports FTC May Not Approve Deal With Walgreens

Rite Aid shares are tanking on reports that the FTC may not approve Walgreens Boots Alliance's acquisition of the company.

Walgreens Beats on Bottom Line

The company's consistency is a testament to management’s commitment to and focus on continued cost improvements and self-help initiatives exclusive of the Rite Aid merger.

Walgreens Misses Revenue but Beats Earnings Target -- Slightly

Walgreens Misses Revenue but Beats Earnings Target -- Slightly

Walgreens has delivered earnings per share beats in eight out of the last nine quarters.

Fred's Pharmacy Reports December Sales

Fred's Pharmacy Reports December Sales

Fred's Inc. ("Fred's Pharmacy" or "the Company") (NASDAQ: FRED) today reported sales for the five-week fiscal month of December and the 11-month year-to-date period ended December 31, 2016.

Dow Jones Loses Momentum on March to 20,000 While Nasdaq Hits Record

Dow Jones Loses Momentum on March to 20,000 While Nasdaq Hits Record

The Nasdaq reached a record high at Tuesday's close, but rising consumer confidence and positive housing-market data weren't enough to push the Dow Jones to 20,000.

Dow Retreats from 20,000 Milestone; Stocks Steady as Oil Closes Higher

Dow Retreats from 20,000 Milestone; Stocks Steady as Oil Closes Higher

The Dow's climb to 20,000 stalled Tuesday, but stocks remained somewhat higher. Consumer confidence is increasing, and housing prices are showing positive signs.

Fred's Swallows Poison Pill as Activist Targets

Fred's Swallows Poison Pill as Activist Targets

It has been quite a December for Fred's (FRED), one of the smaller U.S. pharmacy chains.

Dow Moves Toward 20,000; Stocks Higher as Consumer Confidence Rises

Dow Moves Toward 20,000; Stocks Higher as Consumer Confidence Rises

Stocks were slightly up on Tuesday as the Dow moves toward the 20,000 milestone and consumer confidence increases.

Drugstore Chain Fred's Deal Looks Promising, but Investors Should Be Cautious About the Stock

Drugstore Chain Fred's Deal Looks Promising, but Investors Should Be Cautious About the Stock

The company announced Tuesday that it would acquire 865 Rite Aid stores, but its recent earnings report was mediocre.

Fred's Pharmacy Unanimously Adopts Shareholder Rights Plan

Fred's Pharmacy Unanimously Adopts Shareholder Rights Plan

Fred's Inc. ("Fred's Pharmacy" or the "Company") (NASDAQ:FRED) today announced that its Board of Directors unanimously adopted a shareholder rights plan (the "Rights Plan").

WBA, SBUX, NKE: Jim Cramer's Views

WBA, SBUX, NKE: Jim Cramer's Views

Cramer tells us why he's already sick of Dow 20,000, and also talks about animal spirits.